Skip to content
healthcare.dev

ZIIHERA

NDC 68727-950, zanidatamab-hrii, injection, powder, lyophilized, for solution, from Jazz Pharmaceuticals, Inc..

Product NDC
68727-950
Status
Listed
Labeler
Jazz Pharmaceuticals, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761416
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68727-950 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZANIDATAMAB50 mg/mL

Pharmacologic classes

Bispecific HER2-directed Antibody [EPC]; HER2-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
68727-950-02687270950022 VIAL, SINGLE-DOSE in 1 CARTON (68727-950-02) / 6 mL in 1 VIAL, SINGLE-DOSE (68727-950-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ae5d9425-fae5-4541-a158-150998343348
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68727-950

Use it

Look up 68727-950 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68727-950 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68727-950. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.